Time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US

MR Cooperberg, W Meeks, R Fang, FD Gaylis… - JAMA network …, 2023 - jamanetwork.com
… but are still suboptimal, and local variation is high; improving … Design, Setting, and Participants
This retrospective analysisnatural language processing of clinical records and analysis

Screening for prostate cancer

PF Pinsky, H Parnes - New England Journal of Medicine, 2023 - Mass Medical Soc
… secreted by both normal and malignant prostate epithelial cells, … with localized disease,
clinically significant prostate cancer is … Here, we review the current understanding of the benefits …

Rare histological variants of prostate adenocarcinoma: a national cancer database analysis

C Bronkema, S Arora, A Sood, D Dalela… - The Journal of …, 2020 - auajournals.org
cause of cancer related deaths. In 2019 there were an estimated 174,650 new cases of
prostate cancer and 31,620 prostate cancerprostatic SRC 16% presented with advanced local

Long-term outcomes in patients using protocol-directed active surveillance for prostate cancer

LF Newcomb, JM Schenk, Y Zheng, M Liu, K Zhu… - JAMA, 2024 - jamanetwork.com
… patients with clinically localized prostate cancer whose cases … informed consent under
institutional review board supervision (… Third, prostate cancer has a long natural history and …

… and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer …

BM Wollersheim, KM Van Asselt, HG Van Der Poel… - BMC cancer, 2020 - Springer
… of prostate cancer survivors who have completed primary treatment (prostatectomy or
radiotherapy) for localized prostate cancer… clinically localised prostate Cancer: a systematic …

Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials

A Nabid, N Carrier, E Vigneault, AG Martin… - Radiotherapy and …, 2024 - Elsevier
… a normal level, it was unfeasible to estimate a median time for a normal T recovery with
competing risk analysis. … who recovered T to a normal range and compared normal vs. abnormal …

Overdiagnosis in urologic cancer: for World Journal of Urology Symposium on active surveillance in prostate and renal cancer

L Klotz - World Journal of Urology, 2022 - Springer
… This article reviews the pathological, clinical, social, and … , but the natural history of cells
which may look identical is … value in detecting clinically significant localized prostate cancer [50]. …

ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging

T Penzkofer, AR Padhani, B Turkbey, MA Haider… - European …, 2021 - Springer
… All methods of analysis ultimately aim to guide clinical … relative to the natural history of the
targeted prostate cancer. These … to the disease prevalence of the local population and to have …

The value of real-world data in understanding prostate cancer risk and improving clinical care: examples from Swedish registries

K Beckmann, H Garmo, I Franck Lissbrant, P Stattin - Cancers, 2021 - mdpi.com
… This review describes the various registry-based RWD … of prostate cancer (PCa) aetiology,
natural history and effective … High-risk cancer is divided into localized high-risk cancer or …

SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)

A González del Alba, MJ Méndez-Vidal… - Clinical and …, 2021 - Springer
… Due to the dynamic nature of AR aberrations and the … The impact of concurrent local prostate
radiotherapy with ADT has … In the final OS analysis, median OS was 67.0 months in the …